India develops innovative treatment for Alzheimer’s disease

Researchers at the Institute of Nano Science and Technology have developed a new Alzheimer’s disease therapy based on multifunctional nanoparticles. The development was reported by IANS, a partner of TV BRICS.

Conventional Alzheimer’s therapies usually target only a single pathological feature, which limits their clinical effectiveness.

The new treatment is based on nanoparticles containing green tea polyphenols, a neurotransmitter and an amino acid. These nanoparticles are designed to counter amyloid aggregation, reduce oxidative stress, alleviate inflammation and prevent neuronal degeneration.

The nanoparticles are synthesised using biocompatible methods such as hydrothermal treatment and electrostatic incubation.

The study presents a comprehensive approach that addresses multiple aspects of Alzheimer’s disease, thereby opening up new prospects for its treatment. The nanoparticles are able not only to eliminate plaques but also to lower stress levels in the brain, reduce inflammation and stimulate the growth of nerve cells.

Photo: gorodenkoff / iStock